Rectal cancer in young Indians-Are these cancers different compared to their older counterparts?

被引:18
作者
Barreto S.G. [2 ]
Chaubal G.N. [2 ]
Talole S. [1 ]
DeSouza A. [2 ]
Suradkar K. [2 ]
Gaikwad V. [2 ]
Goel M. [2 ]
Shrikhande S.V. [2 ]
机构
[1] Department of Biostatistics and Epidemiology, Tata Memorial Hospital, Mumbai, 400 012, Parel
[2] Department of Gastrointestinal and Hepatopancreatobiliary Surgical Oncology, Tata Memorial Hospital, Mumbai, 400 012, Parel
关键词
Mortality; Outcomes; Surgery;
D O I
10.1007/s12664-013-0396-0
中图分类号
学科分类号
摘要
Background: The incidence of rectal cancer in young Indians is increasing. Recent evidence suggests a probable existence of noncanonical tumorigenesis pathways in early-onset colorectal cancer patients in India. The aim of the study was to evaluate rectal cancer outcomes in patients ≤40 years with those >40 years. Methods: An analysis of a prospective database of surgically treated rectal cancer patients ≤40 years (group 1) and those >40 years (group 2) over 2 years was performed. Clinicopathological features, perioperative outcomes, and disease-free survival (DFS) were analyzed. Results: Of the 512 patients with colorectal cancer treated surgically, 237 patients (group 1-57 patients; group 2-180 patients) were diagnosed with nonmetastatic rectal adenocarcinoma. Patients in group 1 were more likely to present with locally advanced (stage III) disease (p < 0.005) resulting in a higher proportion of them receiving neoadjuvant chemoradiotherapy (NACT-RT). There was no difference in morbidity and mortality between the two groups. Younger patients had a significantly higher median total and positive lymph node yield (p < 0.003). Patients in group 1 had a significantly lower overall DFS (p < 0.005). Stage-specific DFS also demonstrated a significantly lower trend in stage III patients in group 1. Conclusions: Young rectal cancer patients in India tended to present more frequently with locally advanced tumors resulting in a higher proportion being treated with NACT-RT. Stapled rectal anastomoses could be performed safely in young patients even after NACT-RT. The significantly poorer DFS in young Indian patients with stage III disease was a novel finding and merits further investigation into tumor biology. © 2013 Indian Society of Gastroenterology.
引用
收藏
页码:146 / 150
页数:4
相关论文
共 16 条
[1]
Gupta S., Bhattacharya D., Acharya A.N., Majumdar S., Ranjan P., Das S., Colorectal carcinoma in young adults: a retrospective study on Indian patients: 2000-2008, Colorectal Dis, 12, (2010)
[2]
Nath J., Wigley C., Keighley M.R., Perakath B., Rectal cancer in young adults: a series of 102 patients at a tertiary care centre in India, Colorectal Dis, 11, pp. 475-479, (2009)
[3]
Mohandas K.M., Desai D.C., Epidemiology of digestive tract cancers in India. V. Large and small bowel, Indian J Gastroenterol, 18, pp. 118-121, (1999)
[4]
Siegel R., Jemal A., Ward E., Increase in incidence of colorectal cancer among young men and women in the United States, Cancer Epidemiol Biomarkers Prev, 18, pp. 1695-1698, (2009)
[5]
You Y.N., Dozois E.J., Boardman L.A., Aakre J., Huebner M., Larson D.W., Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort, Ann Surg Oncol, 18, pp. 2469-2476, (2011)
[6]
Mukherji A., Rathi A.K., Sharma K., Kumar V., Singh K., Bahadur A.K., A study on presentation and behavior of colo-rectal carcinoma in young Indian patients, Trop Gastroenterol, 32, pp. 122-127, (2011)
[7]
Cusack J.C., Giacco G.G., Cleary K., Et al., Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma, J Am Coll Surg, 183, pp. 105-112, (1996)
[8]
Smith C., Butler J.A., Colorectal cancer in patients younger than 40 years of age, Dis Colon Rectum, 32, pp. 843-846, (1989)
[9]
Raman R., Kotapalli V., Adduri R., Et al., Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India, Mol Carcinog., (2012)
[10]
Therasse P., Arbuck S., Eisenhauer E., Et al., New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst, 92, pp. 205-216, (2000)